INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 52 filers reported holding INOZYME PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,000 | +9.1% | 5,683 | +44.2% | 0.00% | – |
| Q2 2023 | $22,000 | +1000.0% | 3,940 | +471.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 690 | +47.1% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 469 | -46.9% | 0.00% | – |
| Q1 2022 | $4,000 | -80.0% | 884 | -70.6% | 0.00% | – |
| Q4 2021 | $20,000 | -4.8% | 3,011 | +63.6% | 0.00% | – |
| Q3 2021 | $21,000 | +23.5% | 1,841 | +87.1% | 0.00% | – |
| Q2 2021 | $17,000 | -22.7% | 984 | -12.4% | 0.00% | – |
| Q1 2021 | $22,000 | +340.0% | 1,123 | +328.6% | 0.00% | – |
| Q4 2020 | $5,000 | – | 262 | +2520.0% | 0.00% | – |
| Q3 2020 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,591,154 | $18,441,000 | 6.52% |
| CHI Advisors LLC | 920,264 | $10,666,000 | 3.11% |
| Sofinnova Investments, Inc. | 2,028,308 | $23,508,000 | 1.39% |
| MPM BioImpact LLC | 320,724 | $3,717,000 | 0.58% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,344,786 | $27,176,000 | 0.53% |
| NEA Management Company, LLC | 2,444,379 | $28,330,000 | 0.34% |
| Rock Springs Capital Management LP | 850,015 | $9,852,000 | 0.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 986,400 | $11,432,000 | 0.19% |
| Overbrook Management Corp | 16,726 | $194,000 | 0.04% |
| Orbimed Advisors | 294,000 | $3,407,000 | 0.04% |